Replies to post #356790 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Likability of a CEO determines stock prices?

...there is zero chance this CEO can commercialize anything. Someone else will have to do it.

Sure, that makes a lot of sense.

When very positive safety and efficacy data appear from the completed Phase 3 Parkinson’s disease dementia and Alzheimer’s clinical trials, the entire investment community is going to say, “Well, Anavex will never be able to gain FDA approval for the drug because a bunch of message board people don’t like the guy.”

Makes lots of sense (to some).